Clinical and translational results from the NEOSTAR study treating earlystage lung cancer with nicolumab plus ipilimumab

Clinical and translational results from the NEOSTAR study: treating early-stage lung cancer with nicolumab plus ipilimumab

20:29 EDT 1 Jun 2019 | ecancermedicalscience

Dr Tina Cascone talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about the updated clinical and translational results of the NEOSTAR study. The trial involved treating patients with early-stage, resectable...

More From BioPortfolio on "Clinical and translational results from the NEOSTAR study: treating early-stage lung cancer with nicolumab plus ipilimumab"